
A new review suggests there may be biomarkers linked to irritable bowel syndrome, typically a diagnosis of exclusion.How you get followed up after going to the doctor with symptoms of bowel cancer is shaped in part by where you live.People can now access their diagnostic and pathology results digitally, and for one woman in Brisbane that meant spotting a breast cancer finding that might otherwise have been missed. References:Serological and faecal markers of irritable bowel syndrome: a systematic review and meta-analysisVariations in the investigation of colorectal cancer-related symptoms in Australian primary care: a retrospective cohort studyOutbreak of diptheria in the Kimberley.Nine-Valent Human Papillomavirus Vaccination and Related Cancers in MalesAn estimated 450,000 diabetics will miss out on subsidised Mounjaro after negotiations stalled
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.
Free AI-powered recaps of Health Report and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.